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Summary
Huntington's disease (HD) is an inherited autosomal neurodegenerative disorder affecting predominantly the brain, characterized by motor dysfunctions, behavioral and cognitive disturbances. The aim of this study was to determine changes in the brain of transgenic minipigs before HD onset using 1 H magnetic resonance (MR) spectroscopy.
Measurements were performed on a 3T MR scanner using a single voxel spectroscopy sequence for spectra acquisition in the white matter and chemical shift imaging sequence for measurement in the striatum, hippocampus and thalamus.
A decrease of (phospho)creatine (tCr) concentration was found only in the thalamus (p=0.002) of transgenic minipigs, nevertheless we found significant changes in metabolite ratios. Increase of the ratio choline compounds (tCho)/tCr was found in all examined areas: striatum (p=0.010), thalamus (p=0.011) as well as hippocampus (p=0.027). The ratio Nacetylaspartate+N-acetylaspartylglutamate (tNAA)/tCr (p=0.043) and glutamate+glutamine (Glx)/tCr(p=0.039) was elevated in the thalamus, the ratio myo-inositol (Ins)/tCr (p=0.048) was significantly increased in the hippocampus.
No significant differences were observed in the metabolite concentrations in the white matter, however we found significant increase of ratios tNAA/tCr (p=0.018) and tCho/tCr (p=0.003) ratios in transgenic boars.
We suppose that the majority of the observed changes are predominantly related to changes in energy metabolism caused by decrease of tCr. The number of CAG repeats inversely correlates with the onset and severity of this disease, however, the precise function of the trinucleotide stretch remains unclear (Bano et al. 2011 , Heikkinen et al. 2012 , van den Bogaard et al. 2011 ).
Animal models play crucial roles in understanding pathological mechanisms and in the nature of neurodegeneration in HD and are important for developing therapeutic measures.
Determination of symptom-independent biomarkers of HD neuropathology represents a key task for research, as they may predict disease evolution before its onset (Bohanna et al. 2008, Perez-De La Cruz and Santamaria 2007) .
A large number of rodent models that have various degrees of similarity to the human HD pathology have been developed. From the different transgenic models available, R6/1 and R6/2 mice are most widely studied (Perez-De La Cruz and Santamaria 2007, Zuccato et al. 2010 ). However, the small size of the rodent brain and differences in neurostructure compared to humans limit their application for detailed neuroanatomical characterization (Baxa et al. 2013) . To overcome these problems, larger HD genetic models such as the sheep, minipig, and the non-human primate have been developed (Morton and Howland 2013, Zuccato et al. 2010) The minipig is a suitable species due to big size of gyrencephalic brain and long lifespan. Moreover, there is a 96% similarity between the porcine and human huntingtin genes (Baxa et al. 2013 ).
Studies of HD in humans have revealed extensive changes throughout the brain (Bohanna et al. 2008) . Nevertheless it is still not clear which structures are affected at different disease stages predominantly before the onset of the disease (van den Bogaard et al. 2011) .
Magnetic resonance spectroscopy (MRS) is a non-invasive method used in research and clinical praxis that allows an evaluation of in vivo metabolism at the molecular level (Sundgren et al. 2005) . By using 1 H MRS concentrations of metabolites N-acetylaspartate, creatine, phosphocreatine, glutamate, glutamine, choline-containing compounds, inositol, γ-aminobutyric acid and others can be determined (van den Bogaard et al. 2011) . The aim of this study was to determine changes in the brain of transgenic HD (TgHD) minipigs (model according to (Baxa et al. 2013) ) before HD onset.
To investigate different regions of the brain we used SVS and 2D-CSI MRS. The ability of 2D-CSI technique to determine metabolite changes in various brain regions (striatum, thalamus, and hippocampus) enabled detailed diagnostics of possible brain pathologies in this HD minipig model, whereas SVS was used to obtain information from a substantial part of the white matter (WM). These data could provide a baseline for future MRS at clinical stage. 
Materials and Methods

Minipigs
MRS experiments
Measurements were performed on a whole body 3 T MR scanner (Siemens Magnetom Trio) using a Tx/Rx head coil. For spectra localization, three perpendicular T2-weighted turbo spin echo images (repetition time/echo time TR/TE = 4400/99 ms, 4 mm slice thickness) were Default LCModel water concentration (LCModel parameter: WCONC=35880 mmol/kg) and relaxation times (LCModel parameter: attenuation factor ATTH2O=0.7) for the human brain were used for the calculation of metabolite concentrations. Absolute concentrations of the metabolites were expressed as mmol/kg tissue. The ratios of metabolites to tCr were also determined.
Statistics
For the statistical evaluation only spectra with all evaluated metabolites (tNAA, tCr, tCho, Glx, Ins) having Cramér-Rao lower bound reported by LCModel below 20% were used. This criterion was fulfilled for spectra from 6 HD (SVS) and 5 HD (2D-CSI) and from 6 control (SVS, 2D-CSI) minipigs which were used for further quantification.
The resulting representative concentration of each metabolite measured by 2D-CSI was determined as an average of the concentration values obtained from the spectra of 3-6 voxels (matrix 32x32) in each analyzed area (striatum, thalamus and hippocampus).
The data for each metabolite, or for each metabolite to tCr ratio, was tested for normal distribution (Shapiro -Wilk test) and homogeneity of variance (Levene's tests -absolute and squared deviations) resulting in the confirmation of null hypothesis. The differences between groups were evaluated using two-tailed Student's t-test and p < 0.05 was considered as a statistically significant difference. Corrections for multiple comparisons were not used, as they are not recommended when the study focuses on only a few scientifically sensible comparisons.
Results
White Matter
Metabolite concentrations in the white matter were measured using SVS. Examples of typical spectra from WM (HD and control) are shown in Fig. 2 . The average values of the absolute concentrations of five metabolites (tNAA, tCr, tCho, Glx, Ins) and their ratios to tCr are summarized in Table 1 . No significant differences were observed in the metabolite concentrations alone, however, significant increases of tNAA/tCr (p=0.018) and tCho/tCr (p=0.003) ratios were found in TgHD animals.
Striatum, thalamus, hippocampus
Changes of metabolite concentrations in the striatum, thalamus and hippocampus were determined by the 2D-CSI sequence. Typical spectra from the thalamus in HD and control minipigs are shown in Fig. 3 . As in the case of SVS, five metabolites (tNAA, tCr, tCho, Glx, Ins) have been quantified. Metabolite concentrations and their ratios to tCr in the striatum, thalamus and hippocampus are summarized in Table 2 .
The only significant change in metabolite concentration was a decrease in tCr in the thalamus (p=0.002) of transgenic boars, nevertheless we found significant changes in metabolite ratios.
Increase of the ratio tCho/tCr was found in all examined areas: striatum (p=0.010), thalamus (p=0.011) as well as hippocampus (p=0.027). The ratios tNAA/tCr (p=0.043) and Glx/tCr(p=0.039) were elevated in the thalamus, the ratio Ins/tCr (p=0.048) was significantly increased in the hippocampus.
Discussion
Huntington disease is accompanied by severe changes on a cellular level manifested also by metabolic changes in the brain tissue, however, little is known about the changes before clinical symptoms occur. Therefore we set out to determine changes in the brain metabolites We determined metabolite changes in WM and hippocampus, thalamus and striatum in TgHD minipigs in vivo by using 1 H MRS. Single voxel spectroscopy revealed significant increase of the tCho/tCr and tNAA/tCr ratios in WM of TgHD animals. These changes are probably generated by decreased tCr concentration even when its change alone is not significant in absolute terms, since the difference in absolute tNAA and tCho concentrations are minimal.
Increase of the tNAA/tCr ratio apparently originates from reduced tCr concentration because tNAA increase is unlikely.
A raised choline concentration might also be responsible for an increase of tCho/tCr ratio in WM of TgHD animals. Indeed, increase of tCho has been connected with myelin breakdown (Pouwels et al. 1998 , Zacharoff et al. 2012 and diffusion tensor imaging (DTI) studies in early stage of HD suggested axonal injury and demyelination process in WM (Rosas et al. 2006 , Weaver et al. 2009 ) which might also explain our observation.
It should be noted that a rectangular region of interest (ROI) was not placed in the white matter exclusively but involved also adjacent structures. We assume that a substantial part of the signal measured by SVS MRS in the white matter originated from the cingulate cortex area. With regard to placement of ROI and precision of the measurement, we did not detect changes found in posterior cingulate cortex by Unschuld at al. (Unschuld et al. 2012) , who showed a NAA concentration decline and a lower level of glutamate concentration in posterior cingulate cortex in individuals with the HD mutation.
Although a decrease of tCr concentration in the gray matter in HD patients was reported in several publications (Sturrock et al. 2010 , van den Bogaard et al. 2011 , a decrease in tCr or changes in the metabolite/tCr ratios in WM of TgHD minipigs, before onset of neurological deficit, represents a new piece of information.
Similarly, 2D-CSI revealed a decrease in tCr (absolute concentration) in the thalamus, and also a significantly increased tCho/tCr ratio in all examined areas (striatum, thalamus and hippocampus) of transgenic animals. We also observed significant elevation of the tNAA/tCr and Glx/tCr ratios in the thalamus and of Ins/tCr in hippocampus. All these changes can be explained by a decrease of tCr.
Creatine is an important marker for brain energy metabolism. Lower creatine levels were reported in striatum of HD patients suggesting impaired energy metabolism (van den Bogaard et al. 2011) . In the brain of R6/2 mouse Zacharoff et al. observed the elevations of Cr and PCr between 4 and 8 weeks without further significant changes. They suggested that these changes stem from early stages of the disease (Zacharoff et al. 2012 ).
We found a decrease in tCr similar to observations in human HD studies (van den Bogaard et al. 2011 , Sturrock et al. 2010 , although in a different brain structure (thalamus). The significant elevation of tCho/tCr in all examined areas may also indicate a decrease of tCr.
We may therefore agree with Zacharoff's hypothesis that the changes in Cr and PCr concentrations are related to early stages of HD, although the experiments of Zacharoff et al.
2012, done on R6/2 mice, revealed increased concentrations contrary to our findings.
Changes in the choline concentrations are generally associated with modifications of membrane composition. An increased choline signal was found in Alzheimer's disease or in multiple sclerosis (Govindaraju et al. 2000) , but also in HD (Sturrock et al. 2010) . Hence an increase of tCho/tCr ratio might be also caused by raised choline concentration.
During HD progression alterations of concentrations of tNAA, Glx and Ins were reported (Sturrock et al. 2010 , van den Bogaard et al. 2011 .
tNAA concentration within gray matter indicates neuronal abundance and viability (Sturrock et al. 2010) . Myo-inositol primarily located within astrocytes is considered a gliosis marker (Castillo et al. 2000 , Zacharoff et al. 2012 . Glutamine concentration may increase with gliosis and both glutamine and glutamate can act as osmolytes (Zacharoff et al. 2012 ).
Although we detected a slight non-significant decrease in absolute concentration of tNAA in two-year-old TgHD animals, we did not observe significant changes in absolute concentration values as such and changes of metabolic ratios may be predominantly attributed to decrease of tCr associated to changes in energy metabolism rather than to changes in concentration of tNAA, Glx or Ins.
It should be also noted that HD and control minipigs may react differently to anesthesia, nevertheless similar SDs of average values of metabolite concentrations in both groups indicate that possible differences caused by anesthesia are small and can be neglected.
Default LCModel water concentration and relaxation times for the human brain were used for the calculation of metabolite concentrations. The missing brain tissue segmentation accounting for different water signal contributions of white and gray matter as well as possibly biased relaxation times of both water compartments may lead to systematic shifts in estimated metabolite concentrations. However, since the best effort has been made to keep the 13 VOI position in individual examinations constant the systematic shifts in concentrations were minimized.
The dependence on the water signal is canceled out by the calculation of concentration ratios, i.e., the concentrations were related to tCr. Nevertheless, the resulting concentration ratios may be also influenced by different concentrations of tCr in the white and gray matter.
However, based on the presented results the authors believe that the observed changes in metabolite concentrations/ratios can be ascribed to physiological/biochemical tissue changes as described above.
Conclusion
We found a significant decrease of total creatine concentration in the thalamus and increased metabolic ratios tCho/tCr in the striatum, thalamus, hippocampus as well as white matter of transgenic minipigs before clinical pathology onset. Similarly, increased tNAA/tCr and Glx/tCr ratios were observed in the thalamus. We hypothesized that the majority of the observed changes are predominantly related to changes in energy metabolism.
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